{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:09:11Z","timestamp":1794413351981,"version":"4.9.1"},"reference-count":33,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"publisher","award":["ANR-11-IDEX-0003"],"award-info":[{"award-number":["ANR-11-IDEX-0003"]}],"id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["SPF202209015782"],"award-info":[{"award-number":["SPF202209015782"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2023,9,18]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to analyse the association between infections and the subsequent risk of giant cell arteritis (GCA) and\/or polymyalgia rheumatica (PMR) by a systematic review and a meta-analysis of observational studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two databases (Medline and Embase) were systematically reviewed. Epidemiological studies studying the association between any prior infection and the onset of GCA\/PMR were eligible. Risk of bias was assessed using the Newcastle-Ottawa quality assessment scale. Outcomes and pooled statistics were reported as OR and their 95% CI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eleven studies (10 case\u2013control studies and one cohort study) were analysed, seven of them were included in the meta-analysis. Eight were at low risk of bias. A positive and significant association was found between prior overall infections and prior\n                      <jats:italic>Herpes Zoster<\/jats:italic>\n                      (HZ) infections with pooled OR (95%\u2009CI) of 1.27 (1.18 to 1.37) and 1.20 (1.08 to 1.21), respectively. When analysed separately, hospital-treated and community-treated infections, were still significantly associated with the risk of GCA, but only when infections occurring within the year prior to diagnosis were considered (pooled OR (95%\u2009CI) 1.92 (1.67 to 2.21); 1.67 (1.54 to 1.82), respectively). This association was no longer found when infections occurring within the year prior to diagnosis were excluded.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study showed a positive association between the risk of GCA and prior overall infections (occurring in the year before), and prior HZ infections. Infections might be the reflect of an altered immunity of GCA patients or trigger the disease. However, reverse causation cannot be excluded.<\/jats:p>\n                    <jats:p>CRD42023404089.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003493","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T12:06:25Z","timestamp":1699617985000},"page":"e003493","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Association between infection and the onset of giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"9","author":[{"given":"Lucas","family":"Pacoureau","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Barde","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-1856","authenticated-orcid":false,"given":"Raphaele","family":"Seror","sequence":"additional","affiliation":[{"name":"Auto-immunity team, IMVA, INSERM U1184, Le Kremlin Bic\u00eatre, France"},{"name":"Department of Rheumatology, H\u00f4pital Bic\u00eatre, AP-HP.Sud, Universit\u00e9 Paris Saclay, Le Kremlin-Bicetre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-3824","authenticated-orcid":false,"given":"Yann","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France"},{"name":"Department of Rheumatology, H\u00f4pital Bic\u00eatre, AP-HP.Sud, Universit\u00e9 Paris Saclay, Le Kremlin-Bicetre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"2025090313293021000_9.4.e003493.1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/rheumatology\/keab269","article-title":"Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden-an update on incidence and first prevalence estimate","volume":"61","author":"Stamatis","year":"2021","journal-title":"Rheumatology"},{"key":"2025090313293021000_9.4.e003493.2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/acr.22942","article-title":"Incidence, prevalence, and survival of biopsy-proven giant cell arteritis in northern Italy during a 26-year period","volume":"69","author":"Catanoso","year":"2017","journal-title":"Arthritis Care & Research"},{"key":"2025090313293021000_9.4.e003493.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204652"},{"key":"2025090313293021000_9.4.e003493.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(82)80003-9"},{"key":"2025090313293021000_9.4.e003493.5","first-page":"S15","article-title":"The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations","volume":"25","author":"Bas-Lando","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313293021000_9.4.e003493.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.046912"},{"key":"2025090313293021000_9.4.e003493.7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.semarthrit.2020.05.023","article-title":"A seasonal pattern in the onset of Polymyalgia Rheumatica and giant cell arteritis? A systematic review and meta-analysis","volume":"50","author":"Hysa","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2025090313293021000_9.4.e003493.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.46.12.915"},{"key":"2025090313293021000_9.4.e003493.9","doi-asserted-by":"publisher","DOI":"10.1007\/s001090050074"},{"key":"2025090313293021000_9.4.e003493.10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.autrev.2017.05.004","article-title":"New insights into the pathogenesis of giant cell arteritis","volume":"16","author":"Ciccia","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2025090313293021000_9.4.e003493.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.161"},{"key":"2025090313293021000_9.4.e003493.12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamaneurol.2015.2101","article-title":"Analysis of Varicella-Zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis","volume":"72","author":"Nagel","year":"2015","journal-title":"JAMA Neurol"},{"key":"2025090313293021000_9.4.e003493.13","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000216","article-title":"VZV in biopsy-positive and -Negative giant cell arteritis: analysis of 100+ temporal arteries","volume":"3","author":"Gilden","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025090313293021000_9.4.e003493.14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/infdis\/jiaa566","article-title":"No evidence of Varicella-Zoster virus infection in temporal artery biopsies of anterior ischemic optic neuropathy patients with and without giant cell arteritis","volume":"223","author":"Verdijk","year":"2021","journal-title":"J Infect Dis"},{"key":"2025090313293021000_9.4.e003493.15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/01658107.2019.1604763","article-title":"Varicella Zoster virus in giant cell arteritis: A review of current medical literature","volume":"43","author":"Ostrowski","year":"2019","journal-title":"Neuro-Ophthalmology"},{"key":"2025090313293021000_9.4.e003493.16","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02438-08"},{"key":"2025090313293021000_9.4.e003493.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330810"},{"key":"2025090313293021000_9.4.e003493.18","doi-asserted-by":"crossref","unstructured":"Dasgupta B . Classification criteria and guidelines for Polymyalgia Rheumatica. Rheumatology (Oxford) 2013:i21. doi:10.1093\/rheumatology\/ket193","DOI":"10.1093\/med\/9780199642489.003.0134"},{"key":"2025090313293021000_9.4.e003493.19","unstructured":"Wells G , Shea B , O\u2019Connell D , et al . n.d. The Newcastle-Ottawa scale (NOS) for assessing the quality of Nonrandomized studies in Meta- analysis."},{"key":"2025090313293021000_9.4.e003493.20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1937586717747384","article-title":"How to write a systematic review of the literature","volume":"11","author":"Pati","year":"2018","journal-title":"HERD"},{"key":"2025090313293021000_9.4.e003493.21","first-page":"361","article-title":"Giant cell arteritis, Polymyalgia Rheumatica, and viral hypotheses: a multicenter, prospective case-control study","volume":"26","author":"Duhaut","year":"1999","journal-title":"J Rheumatol"},{"key":"2025090313293021000_9.4.e003493.22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.39.5.511"},{"key":"2025090313293021000_9.4.e003493.23","first-page":"200","article-title":"Is Polymyalgia Rheumatica caused by infectious agents","volume":"32","author":"Nuti","year":"2005","journal-title":"J Rheumatol"},{"key":"2025090313293021000_9.4.e003493.24","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2147\/CLEP.S158293","article-title":"Does low risk of infections as a marker of effective immunity predict increased risk of subsequent giant cell arteritis or Polymyalgia Rheumatica? A Danish population-based case-control study","volume":"10","author":"Brault","year":"2018","journal-title":"Clin Epidemiol"},{"key":"2025090313293021000_9.4.e003493.25","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/art.40236","article-title":"Herpes Zoster as a risk factor for incident giant cell arteritis","volume":"69","author":"England","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090313293021000_9.4.e003493.26","first-page":"1303","article-title":"Are there any identifiable triggers in Polymyalgia Rheumatica A matched-control study","volume":"71","author":"Jaramillo","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025090313293021000_9.4.e003493.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210152"},{"key":"2025090313293021000_9.4.e003493.28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/art.1780380312","article-title":"Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism","volume":"38","author":"Russo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2025090313293021000_9.4.e003493.29","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/rheumatology\/kez556","article-title":"Assessment for Varicella Zoster virus in patients newly suspected of having giant cell arteritis","volume":"59","author":"Sammel","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025090313293021000_9.4.e003493.30","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200211"},{"key":"2025090313293021000_9.4.e003493.31","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440323"},{"key":"2025090313293021000_9.4.e003493.32","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.025320"},{"key":"2025090313293021000_9.4.e003493.33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.semarthrit.2017.02.005","article-title":"No detection of Varicella-Zoster virus in temporal arteries of patients with giant cell arteritis","volume":"47","author":"Muratore","year":"2017","journal-title":"Semin Arthritis Rheum"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:29:41Z","timestamp":1756931381000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,10]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/rmdopen-2023-003493"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003493","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}